Literature DB >> 22692665

Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study.

Maria Fusaro1, Marianna Noale, Valentina Viola, Francesco Galli, Giovanni Tripepi, Nicola Vajente, Mario Plebani, Martina Zaninotto, Giuseppe Guglielmi, Diego Miotto, Luca Dalle Carbonare, Angela D'Angelo, Agostino Naso, Cristina Grimaldi, Davide Miozzo, Sandro Giannini, Maurizio Gallieni.   

Abstract

Vitamin K (vitamin K1 or phylloquinone and vitamin K2, a series of menaquinones [MKs]) is involved in the production of bone and matrix amino acid γ-carboxy-glutamic acid (Gla) proteins, regulating bone and vascular calcification. Low vitamin K concentrations are associated with increased risks of fractures and vascular calcification, and frequent complications in hemodialysis patients. We carried out an observational study to establish the prevalence of vitamin K deficiency and to assess the relationship between vitamin K status, vertebral fractures, vascular calcification, and survival in 387 patients on hemodialysis for ≥1 year. We determined plasma levels of vitamin K compound, bone-Gla-protein, matrix-Gla-protein, and routine biochemistry. Vertebral fractures (reduction in vertebral body height by ≥20%) and aortic and iliac calcifications were also investigated in a spine (D(5) -L(4)) radiograph. Three-year patient survival was analyzed. Important proportions of patients had deficiency of MK7 (35.4%), vitamin K1 (23.5%), and MK4 (14.5%). A total of 55.3% of patients had vertebral fractures, 80.6% had abdominal aorta calcification, and 56.1% had iliac calcification. Vitamin K1 deficiency was the strongest predictor of vertebral fractures (odds ratio [OR], 2.94; 95% confidence interval [CI], 1.38-6.26). MK4 deficiency was a predictor of aortic calcification (OR, 2.82; 95% CI, 1.14-7.01), whereas MK5 deficiency actually protected against it (OR, 0.38; 95% CI, 0.15-0.95). MK7 deficiency was a predictor of iliac calcification (OR, 1.64; 95% CI, 1.03-2.60). The presence of vertebral fractures was also a predictor of vascular calcifications (OR, 1.76; 95% CI, 1.00-3.08). Increased alkaline phosphatase and C reactive protein (CRP), age, and cerebrovascular events were predictors of mortality. Our study suggests that the vitamin K system may be important for preserving bone mass and avoiding vascular calcification in hemodialysis patients, pointing out a possible role of vitamin K in bone and vascular health. Based on our results, we suggest that the general population should also be studied for vitamin K deficiency as a possible cause of both vertebral fractures and vascular calcification.
Copyright © 2012 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692665     DOI: 10.1002/jbmr.1677

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  50 in total

Review 1.  Vitamin K in CKD Bone Disorders.

Authors:  M Fusaro; G Cianciolo; P Evenepoel; L Schurgers; M Plebani
Journal:  Calcif Tissue Int       Date:  2021-01-06       Impact factor: 4.333

Review 2.  Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

Authors:  Maria Fusaro; Maurizio Gallieni; Camillo Porta; Thomas L Nickolas; Pascale Khairallah
Journal:  J Nephrol       Date:  2019-12-19       Impact factor: 3.902

Review 3.  Vitamin K status in chronic kidney disease: a report of a study and a mini-review.

Authors:  Kieran Voong; Dominic Harrington; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-01-08       Impact factor: 2.370

4.  Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins.

Authors:  Maria Fusaro; Sandro Giannini; Maurizio Gallieni; Marianna Noale; Giovanni Tripepi; Maurizio Rossini; Piergiorgio Messa; Paolo Rigotti; Tecla Pati; Francesco Barbisoni; Antonio Piccoli; Andrea Aghi; Marianna Alessi; Luciana Bonfante; Fabrizio Fabris; Sabina Zambon; Stefania Sella; Giorgio Iervasi; Mario Plebani
Journal:  Endocrine       Date:  2015-07-01       Impact factor: 3.633

5.  Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus.

Authors:  Maria Fusaro; Maurizio Gallieni; Andrea Aghi; Maria Antonietta Rizzo; Giorgio Iervasi; Thomas L Nickolas; Fabrizio Fabris; Maria Cristina Mereu; Sandro Giannini; Stefania Sella; Andrea Giusti; Annalisa Pitino; Graziella D'Arrigo; Maurizio Rossini; Davide Gatti; Maura Ravera; Luca Di Lullo; Antonio Bellasi; Giuliano Brunori; Antonio Piccoli; Giovanni Tripepi; Mario Plebani
Journal:  J Nephrol       Date:  2019-02-13       Impact factor: 3.902

6.  Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zhihui Yao; Congxia Wang; Qiaona Zhang; Shan Ma; Baosong Gui; Chaoyang Duan
Journal:  Int Urol Nephrol       Date:  2017-09-21       Impact factor: 2.370

Review 7.  Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.

Authors:  Hanne Skou Jørgensen; Karel David; Syazrah Salam; Pieter Evenepoel
Journal:  Calcif Tissue Int       Date:  2021-02-14       Impact factor: 4.333

Review 8.  Vitamin K and bone.

Authors:  Maria Fusaro; Maria Cristina Mereu; Andrea Aghi; Giorgio Iervasi; Maurizio Gallieni
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

9.  Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients.

Authors:  Maria Fusaro; Maurizio Gallieni; Paola Rebora; Maria Antonietta Rizzo; Maria Carmen Luise; Hilary Riva; Silvio Bertoli; Ferruccio Conte; Andrea Stella; Patrizia Ondei; Emanuela Rossi; Maria Grazia Valsecchi; Antonio Santoro; Simonetta Genovesi
Journal:  J Nephrol       Date:  2015-10-22       Impact factor: 3.902

10.  Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.

Authors:  M Atteritano; E Di Mauro; V Canale; A M Bruzzese; C A Ricciardi; V Cernaro; A Lacquaniti; M Buemi; D Santoro
Journal:  Osteoporos Int       Date:  2016-09-28       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.